What is the onset of action of terbutaline (beta-2 adrenergic agonist) when administered via inhalation for acute relief of bronchospasm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Onset of Action of Terbutaline

Terbutaline begins working within 5 minutes when administered by inhalation for acute bronchospasm relief. 1, 2

Route-Specific Onset Times

Inhaled Terbutaline (Fastest)

  • Onset of action: 5 minutes when administered via metered-dose inhaler or nebulizer 1, 2
  • Provides the most rapid bronchodilation compared to other routes of administration 1
  • Peak effect occurs within 30-60 minutes 3
  • Duration of action: 4-6 hours 3

Subcutaneous Terbutaline

  • Onset of action: within 5 minutes at doses of 0.25-0.50 mg 1
  • The American Heart Association guidelines note terbutaline can be given subcutaneously at 0.25 mg, repeated every 20 minutes for up to 3 doses in acute severe asthma 3
  • However, there is no evidence that subcutaneous terbutaline has advantages over inhaled β2-agonists 3

Clinical Implications

Why Inhaled Route is Preferred

  • Inhaled terbutaline offers the fastest onset, maximal response, and longest duration compared to subcutaneous or oral routes 1
  • Produces fewer cardiovascular side effects (less tachycardia and tremor) than subcutaneous administration 4, 5
  • When delivered via spacer device, inhaled terbutaline is at least as effective as subcutaneous adrenaline for acute severe asthma, with better tolerability 4

Important Caveats

  • The dose delivered by inhalation depends on the patient's lung volume and inspiratory flow rate 3
  • Proper inhaler technique must be demonstrated and rechecked periodically, as many patients use inhalers incorrectly 3
  • If metered-dose inhaler technique is inadequate, consider using a spacer device or nebulizer 3, 4
  • Regular use (≥4 times daily) does not affect potency but reduces duration of action 3

Dosing for Acute Bronchospasm

  • Inhaled: 0.375-0.50 mg (typically 2 puffs of 0.25 mg each) provides highly effective relief within 5 minutes 1, 5
  • Higher doses (up to 4 mg via dry powder inhaler) can achieve more rapid onset, greater maximal response, and longer duration with minimal adverse effects 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.